Nov 13, 2018 InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.
Aug 14, 2018 Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
Jun 06, 2018 Avenue Therapeutics to Host Key Opinion Leader Call on Intravenous (IV) Tramadol for the Management of Postoperative Pain
May 21, 2018 Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
May 03, 2018 Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
Mar 28, 2018 Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol
Mar 01, 2018 Avenue Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Corporate Highlights
Feb 06, 2018 Avenue Therapeutics to Participate in Panel on Opioid Abuse at BIO CEO & Investor Conference
